drugset
drugset / Trial / NCT01984099

RCT on the Efficacy of Methotrexate for the Prevention of GTD

NCT01984099 ↗

Phase 3 Completed 99 enrolled University of the Philippines
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized, controlled trial to evaluate the efficacy of methotrexate for the prevention of postmolar gestational trophoblastic disease among patients with high-risk hydatidiform mole.

Timeline

Start
2011-12
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule 0.4 mg/kg Intramuscular

Indications

hydatidiform mole